BetterLife Obtains TD-0148A Receptor Binding Data for IND-Enabling Pharmacology Studies
October 29, 2021
Ryan Allway October 29th, 2021 Psychedelics VANCOUVER, British Columbia, Sept. 29, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to... Read more
